Q&A with Colleen Kelly: Treatment Options for C. Difficile Infections


C. Difficile is big. It has surpassed MRSA as the most common hospital acquired infection.

Colleen Kelly, MD, FACG, Brown University shared at the 2015 American College of Gastroenterology Annual Scientific Meeting that they're seeing more C. Diff infections in even populations of people that were previously thought to be at low risk.

As such, Kelly and colleagues work to stratify it by how severe the infection is and what antibiotics to use to treat mild/moderate to more severe infections.

Related Videos
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
Ghada Bourjeily, MD: Research Gaps on Sleep Issues During Pregnancy
John Winkelman, MD, PhD: When to Use Low-Dose Opioids for Restless Legs Syndrome
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
Jennifer Martin, PhD: Boosting CPAP Adherence in Women with Sleep Apnea
© 2024 MJH Life Sciences

All rights reserved.